Global Women Health Disease Diagnosis & Treatment Market Size study & Forecast, by Type (Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, Osteoporosis), End User (Hospitals, clinics, diagnostic centers) and Regional

Global Women Health Disease Diagnosis & Treatment Market Size study & Forecast, by Type (Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, Osteoporosis), End User (Hospitals, clinics, diagnostic centers) and Regional Analysis, 2022-2029

Global Women Health Disease Diagnosis & Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Women Health Disease Diagnosis & Treatment is defined as the field of medicine which is concerned with the treatment and diagnosis of diseases and conditions that have an effect on a woman's health. Menopause, pregnancy, breast cancer, ovarian cancer, cervical cancer, and menopause are just a few examples of the numerous issues unique to women that can be identified through screening, testing, or diagnosis in the field of women's health. Many different tests can be used to identify conditions that have an impact on the health of women. By spotting cancer, removing obstructions, and capturing photos of internal organs, medical diagnostic tools such as mammography, imaging and monitoring systems, biopsy instruments, and others assist doctors screen for and diagnosing disorders. The increasing number of women’s health disorders and growing awareness concerning women’s healthcare are key factors driving the market growth.

The increasing prevalence of various health disorders among women is contributing towards the growth of the Global Women Health Disease Diagnosis & Treatment Market. For instance – as per Centers for Disease Control & Prevention (CDC) estimates – in the United States around 10% of women (6.1 million) aged 15–44 years are affected by reproductive diseases. Additionally, as per World Health Organization (WHO) estimates – as of 2020, globally around 48 million couples and 186 million individuals have infertility. Also, favorable government initiatives pertaining to women’s health as well as rising healthcare spending in developing regions would create lucrative growth opportunities for the market over the forecast period. However, the high cost associated with women’s health disease diagnosis solutions & treatment procedures as well as side effects caused by various drugs impedes the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Women Health Disease Diagnosis & Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the growing prevalence of PCOS and postmenopausal osteoporosis, increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the rising prevalence of the reproductive disease among women as well as growing healthcare spending coupled with favorable initiatives from government authorities to promote women’s well-being in the region would offer lucrative growth opportunities for the market over the forecast period.

Major market player included in this report are:
General Electric Company (US)
CooperSurgical Inc. (US)
ASCEND Therapeutics US, LLC. (US)
Rinovum Women's Health, LLC. (US)
Quest Diagnostics Incorporated (US)
Hologic, Inc. (US)
PerkinElmer, Inc. (US)
Cardinal Health, Inc (US)
Becton, Dickinson, and Company (US)
Abbott Laboratories (US)

Recent Developments in the Market:
 In December 2019, India based Drug maker Mankind Pharma launched new generic Dydrogesterone tablets for treatment of infertility and pregnancy related complications. Moreover, with this new launch the company has become the first Indian and second global firm to develop the drug, Mankind Pharma.

Global Women Health Disease Diagnosis & Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type
Urinary Tract Infection and Condition
Prenatal Reproductive Health
Menopause
Cancer
Osteoporosis
By End User
Hospitals
Clinics
diagnostic centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

General Electric Company (US)
CooperSurgical Inc. (US)
ASCEND Therapeutics US, LLC. (US)
Rinovum Women's Health, LLC. (US)
Quest Diagnostics Incorporated (US)
Hologic, Inc. (US)
PerkinElmer, Inc. (US)
Cardinal Health, Inc (US)
Becton, Dickinson, and Company (US)
Abbott Laboratories (US)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.